Continuous manufacturing is continuing to gain momentum in pharmaceutical and biotech industries, with a demand for greater quality assurance and product consistency. Driven by the potential to increase control over product quality, decrease costs and significantly speed time to market, companies are reviewing the possibilities of implementing continuous processes to certain products. However, the road from batch to continuous manufacturing requires a shift in mindset, especially as it is still new for many pharmaceutical companies. In this interactive infographic we evaluate the benefits of moving from batch approach to continuous manufacturing and the hurdles along the way.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |